2-Butyl-3-(p-tolyl)quinuclidine (BTQ) is a stimulant DRI.

[1] It is one of a number of substituted quinuclidine derivatives developed as potential medications for the treatment of cocaine abuse,[2] and produces similar effects to cocaine in animal studies, although milder and longer-lasting.

This drug article relating to the nervous system is a stub.

You can help Wikipedia by expanding it.